Bladder cancer imaging.
After completing this article, readers should be able to: * Cite risk factors associated with bladder cancer: * Describe the normal anatomy and physiology of the urinary bladder. * List the clinical signs and symptoms of bladder cancer. * Summarize the diagnostic imaging technologies available for
Bladder cancer imaging.
After completing this article, readers should be able to: * Cite risk factors associated with bladder cancer. * Describe the normal anatomy and physiology of the urinary bladder. * List the clinical signs and symptoms of bladder cancer. * Summarize the diagnostic imaging technologies available for
Bladder Cancer
Bladder cancer Definition Bladder cancer is a disease in which the cells lining the urinary bladder lose the ability to regulate their growth and start dividing uncontrollably. This abnormal growth results in a mass of cells that form a tumor. Description The urinary bladder is a hollow muscular
MR imaging in the evaluation of bladder cancer
Bladder cancer is a common tumor of the urinary tract, accounting for 6% to 8% of male malignancies and 2% to 3% of female malignancies.1 The most common histologie cell type is transitional cell carcinoma, accounting for 90% of all primary tumors of the urinary bladder. The remaining 5% to 10% of
BLADDER CANCER: Who's at Risk?
Bladder cancer is the most common urinary-tract malignancy. A recent survey of veterans explores factors linked to developing this disease. In 1997, Joseph Binard, M.D., retired Department of Veterans Affairs (VA) chief of SCI Services in Tampa, asked the Eastern Paralyzed Veterans Association
A First for Rhode Island Firefighters - Bladder Cancer Screening is Underway in Five Communities with the NMP22 BladderChek Test.
Bladder Cancer Screening Program Provided by RI State Reps and Supported by Fire Chiefs; Officials Introducing Legislation to Make Annual Bladder Cancer Testing Available to all Rhode Island Firefighters NEWTON, Mass. - In a first for Rhode Island, firefighters in Little Compton, Tiverton,
Intravesical Bacillus Calmette-Guerin for treating bladder cancer. .
Bladder cancer continues to be a leading cause of malignant neoplasm in men. Since 1976, Bacillus Calmette-Guerin (BCG) has been a recommended treatment for superficial bladder malignancy BCG treatment indications, administration, side effects, patient education, and nursing implications are
Bladder cancer: a complex puzzle.
If you use a catheter all the time: * Will you develop bladder cancer? * Is the risk of this disease higher among SCI survivors? * Do indwelling catheters increase risk? * What can you do to reduce risk? The answers lie in knowing your own susceptibility, understanding your choices, and making
Predictive value of p53 and NAT2 enzyme for disease free survival in patients with superficial bladder cancer
Considering the higher recurrence rates in superficial bladder cancer, p53 immunoreactivity together with functional differences of N-acetytransferase-2 (NAT2) enzymes were studied to evaluate their overall effects on disease free survival rates (DFS) in 45 patients with superficial bladder cancer.
Use of high-throughput DNA microarrays to identify biomarkers for bladder cancer
Review Background: Numerous markers have been described to correlate to some extent with tumor stage and prognosis of patients with bladder cancer. The power of many of these biomarkers in detecting superficial disease or predicting the clinical outcome of individual tumors is limited, and
